Resultados de la búsqueda 251-260 of 20448 for Two-phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. Mayo Clinic will not be participating in the QTC sub-study ...

  3. Oncología (médica) - Ensayos clínicos

    The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  5. Oncología (médica) - Ensayos clínicos

    Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients ... The study will be performed in two phases: Phase I will be performed ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  7. Oncología (médica) - Ensayos clínicos

    The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

  8. Oncología (médica) - Ensayos clínicos

    The study will be performed in two phases: Phase I will be performed for ... Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis ... Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...